King Wealth Management Group’s GSK GSK Stock Holding History

King Wealth Management Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,160	Closed	-$243K	–	159
2020 Q3	$243K	Buy	+5,160	New	+$259K	0.06%	135
2018 Q2	–	Sell	-4,223	Closed	-$206K	–	123
2018 Q1	$206K	Buy	+4,223	New	+$197K	0.07%	119
2017 Q4	–	Sell	-8,712	Closed	-$442K	–	126
2017 Q3	$442K	Sell	8,712 -235	-3%	-$11.9K	0.16%	76
2017 Q2	$482K	Sell	8,947 -44	-0.5%	-$2.35K	0.19%	69
2017 Q1	$474K	Sell	8,991 -158	-2%	-$8.02K	0.2%	69
2016 Q4	$440K	Buy	9,149 +1,063	+13%	+$52.5K	0.2%	67
2016 Q3	$436K	Buy	8,086 +1,040	+15%	+$57K	0.22%	63
2016 Q2	$382K	Buy	7,046 +1,338	+23%	+$70.5K	0.2%	62
2016 Q1	$289K	Buy	5,708 +320	+6%	+$15.9K	0.16%	75
2015 Q4	$272K	Sell	5,388 -660	-11%	-$33.6K	0.15%	82
2015 Q3	$291K	Sell	6,048 -264	-4%	-$13.7K	0.18%	77
2015 Q2	$329K	Buy	6,312 +622	+11%	+$35K	0.18%	73
2015 Q1	$328K	Sell	5,690 -3,626	-39%	-$208K	0.19%	67
2014 Q4	$498K	Buy	+9,316	New	+$521K	0.26%	60

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

King Wealth Management Group's GSK Position: Q4 2020 in Review

King Wealth Management Group sold out of GSK (GSK) in Q4 2020, closing a stake of 5,160 shares — an estimated $243K sold.

King Wealth Management Group first reported a position in GSK in Q4 2014 and held it in 14 quarters. The position peaked at $498K in Q4 2014. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

King Wealth Management Group reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
King Wealth Management Group sold 5,160 GSK shares in Q4 2020, an estimated $243K.
King Wealth Management Group first reported a position in GSK in Q4 2014 and held it in 14 quarters.
King Wealth Management Group's GSK position peaked at $498K in Q4 2014.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on King Wealth Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.